SEARCH RESULTS FOR: "Tag: SRPT"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(9)
2018(8)
2017(17)
2016(45)
2015(10)
2014(3)
CATEGORIES
Analyst Downgrades(4)
Analyst Update(13)
Analyst Upgrades(11)
Best and Worst Stocks(2)
Buzz Stocks(12)
By the Numbers(3)
Expectational Analysis(2)
General(4)
Indexes and ETFs(1)
Intraday Option Activity(14)
Midday Market Check(9)
Most Active Options Update(1)
Most Active Weekly Options(3)
Opening View(8)
Overseas Trading(1)
Quantitative Analysis(4)
Stock Market News(15)
Stocks On the Move(21)
Technical Analysis(2)
Unusual Trading Activity(1)

11/1/2019 12:06 PM
Sarepta Therapeutics Inc (NASDAQ:SRPT) stock is up 4.3% today to trade at $86.63, after Guggenheim initiated coverage with a "buy" rating and a $183 price target -- a 120% premium to last night's clos...
10/2/2019 12:00 PM
Drug stocks have underperformed recently, with just 19% of the 130 stocks we track under the "Pharmaceuticals & Biotechnology" umbrella trading north of their 80-day moving average. Analysts have bare...
8/20/2019 10:11 AM
Sarepta Therapeutics Inc (NASDAQ:SRPT) is near the bottom of the Nasdaq this morning, down 16.5% to trade at $100.52. Last night, the Food and Drug Administration (FDA) declined to approve the company...
8/20/2019 9:23 AM
Dow Jones Industrial Average (DJI) futures are trading cautiously above fair this morning, following a volatile stretch for the blue-chip index that saw six triple-digit closes in the last eight d...
6/28/2019 3:03 PM
The Dow is trading higher today, as financial stocks get a boost after the Fed's annual stress tests. Several individual stocks were making news too, including Sarepta Therapeutics Inc (NASDAQ:SRPT)...
Partner Center